EFFICACY AND SAFETY OF CORTICOSTEROID, PLATELET-RICH PLASMA, AND AUTOLOGOUS BLOOD INJECTIONS IN THE TREATMENT OF LATERAL EPICONDYLITIS: A RANDOMIZED, CONTROLLED CLINICAL TRIAL

Main Article Content

Dr. Ravindra Kumar Singh
Dr. Ajay Kumar Kundan
Dr. Meenakshi Singh

Keywords

Corticosteroid Injection, Grip Strength, Lateral Epicondylitis, Platelet-Rich Plasma

Abstract

Background: Lateral epicondylitis is a common musculoskeletal disorder that affects a significant proportion of the adult population. This study aimed to compare the efficacy and safety of corticosteroid, platelet-rich plasma (PRP), and autologous blood injections in the treatment of lateral epicondylitis.


Methods: A randomized, controlled clinical trial was conducted with 54 patients diagnosed with unilateral chronic lateral epicondylitis. Participants were randomly allocated to three treatment groups: corticosteroid and local anesthetic, PRP, and autologous blood. Pain, function, and grip strength were assessed using a visual analogue scale, the Disabilities of the Arm, Shoulder, and Hand questionnaire, and dynamometer testing at baseline and 1, 2, 4, 12, and 24 weeks post-injection.


Results: All treatment groups demonstrated significant improvements in pain, function, and grip strength from baseline. The corticosteroid group showed the most rapid improvement at 4 weeks, while the PRP group exhibited the greatest long-term benefits at 12 and 24 weeks. The autologous blood group had outcomes similar to the PRP group, but with a lower magnitude of improvement. Adverse events were minor and transient, with no serious complications reported.


Conclusion: PRP and autologous blood injections provided more sustained long-term benefits in the treatment of lateral epicondylitis compared to corticosteroids. While corticosteroids offered rapid short-term relief, PRP and autologous blood injections resulted in superior pain reduction, functional improvement, and patient satisfaction at 12 and 24 weeks post-injection. These findings support the use of PRP and autologous blood injections as effective and safe treatment options for chronic lateral epicondylitis.

Abstract 47 | pdf Downloads 17

References

1. Ahmad, Z., Siddiqui, N., Malik, S. S., Abdus-Samee, M., Tytherleigh-Strong, G., & Rushton, N. (2013). Lateral epicondylitis: A review of pathology and management. Bone & Joint Journal, 95-B(9), 1158-1164. https://doi.org/10.1302/0301-620X.95B9.29285
2. Arirachakaran, A., Sukthuayat, A., Sisayanarane, T., Laoratanavoraphong, S., Kanchanatawan, W., &Kongtharvonskul, J. (2016). Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: Systematic review and network meta-analysis. Journal of Orthopaedics and Traumatology, 17(2), 101-112. https://doi.org/10.1007/s10195-015-0376-5
3. Bisset, L., Paungmali, A., Vicenzino, B., &Beller, E. (2005). A systematic review and meta-analysis of clinical trials on physical interventions for lateral epicondylalgia. British Journal of Sports Medicine, 39(7), 411-422. https://doi.org/10.1136/bjsm.2004.016170
4. Coombes, B. K., Bisset, L., &Vicenzino, B. (2010). Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: A systematic review of randomised controlled trials. The Lancet, 376(9754), 1751-1767. https://doi.org/10.1016/S0140-6736(10)61160-9
5. Coombes, B. K., Bisset, L., &Vicenzino, B. (2015). Management of lateral elbow tendinopathy: One size does not fit all. Journal of Orthopaedic & Sports Physical Therapy, 45(11), 938-949. https://doi.org/10.2519/jospt.2015.5841
6. deVos, R. J., Windt, J., & Weir, A. (2014). Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: A systematic review. British Journal of Sports Medicine, 48(12), 952-956. https://doi.org/10.1136/bjsports-2013-093281
7. Kraushaar, B. S., &Nirschl, R. P. (2001). Tendinosis of the elbow (tennis elbow). Clinical features and findings of histological, immunohistochemical, and electron microscopy studies. The Journal of Bone and Joint Surgery. American Volume, 81(2), 259-278. https://doi.org/10.2106/00004623-199902000-00014
8. Mishra, A., &Pavelko, T. (2006). Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. The American Journal of Sports Medicine, 34(11), 1774-1778. https://doi.org/10.1177/0363546506288850
9. Mishra, A., Woodall, J., Jr, & Vieira, A. (2009). Treatment of tendon and muscle using platelet-rich plasma. Clinics in Sports Medicine, 28(1), 113-125. https://doi.org/10.1016/j.csm.2008.08.007
10. Nirschl, R. P., & Pettrone, F. A. (2001). Tennis elbow. The surgical treatment of lateral epicondylitis. The Journal of Bone and Joint Surgery. American Volume, 61(6A), 832-839.
11. Scutt, N., Rolf, C. G., &Scutt, A. (2006). Glucocorticoids inhibit tenocyte proliferation and tendon progenitor cell recruitment. Journal of Orthopaedic Research, 24(2), 173-182. https://doi.org/10.1002/jor.20030
12. Shiri, R., &Viikari-Juntura, E. (2011). Lateral and medial epicondylitis: Role of occupational factors. Best Practice & Research. Clinical Rheumatology, 25(1), 43-57. https://doi.org/10.1016/j.berh.2011.01.013
13. Shiri, R., Viikari-Juntura, E., Varonen, H., &Heliövaara, M. (2006). Prevalence and determinants of lateral and medial epicondylitis: A population study. American Journal of Epidemiology, 164(11), 1065-1074. https://doi.org/10.1093/aje/kwj325
14. Smidt, N., Assendelft, W. J., Arola, H., Malmivaara, A., Greens, S., Buchbinder, R., van der Windt, D. A., &Bouter, L. M. (2002). Effectiveness of physiotherapy for lateral epicondylitis: A systematic review. Annals of Medicine, 34(1), 51-62. https://doi.org/10.1080/078538902317338634
15. Vaquero-Picado, A., Barco, R., &Antuña, S. A. (2016). Lateral epicondylitis of the elbow. EFORT Open Reviews, 1(11), 391-397. https://doi.org/10.1302/2058-5241.1.000049
16. Vicenzino, B., Brooksbank, J., Minto, J., Offord, S., &Paungmali, A. (2003). Initial effects of elbow taping on pain-free grip strength and pressure pain threshold. Journal of Orthopaedic & Sports Physical Therapy, 33(7), 400-407. https://doi.org/10.2519/jospt.2003.33.7.400
17. Waseem, M., Nuhmani, S., Ram, C. S., & Sachin, Y. (2012). Lateral epicondylitis: A review of the literature. Journal of Back and Musculoskeletal Rehabilitation, 25(2), 131-142. https://doi.org/10.3233/BMR-2012-0328
18. Zhang, J., Wang, J. H., Rodeo, S. A., &Cugat, R. (2013). Platelet-rich plasma for the treatment of tendon and ligament injuries. Operative Techniques in Orthopaedics, 23(1), 54-60. https://doi.org/10.1053/j.oto.2013.03.001
19. Chen, Y., Hu, C. L., Hong, C. K., Hsu, K. L., Kuan, F. C., Chen, W. L., ... & Hwang, I. S. (2023). Deficits in neuromuscular control of increasing force in patients with chronic lateral epicondylitis. Frontiers in Physiology, 14, 1178557. frontiersin.org
20. Ahmad, Z., Siddiqui, N., Malik, S. S., Abdus-Samee, M., Tytherleigh-Strong, G., & Rushton, N. (2013). Lateral epicondylitis: A review of pathology and management. Bone & Joint Journal, 95-B(9), 1158-1164. https://doi.org/10.1302/0301-620X.95B9.29285
21. Arirachakaran, A., Sukthuayat, A., Sisayanarane, T., Laoratanavoraphong, S., Kanchanatawan, W., &Kongtharvonskul, J. (2016). Platelet-rich plasma versus autologous blood versus steroid injection in lateral epicondylitis: Systematic review and network meta-analysis. Journal of Orthopaedics and Traumatology, 17(2), 101-112. https://doi.org/10.1007/s10195-015-0376-5
22. Bisset, L., Beller, E., Jull, G., Brooks, P., Darnell, R., &Vicenzino, B. (2006). Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: Randomised trial. BMJ, 333(7575), 939. https://doi.org/10.1136/bmj.38961.584653.AE
23. Bisset, L., Paungmali, A., Vicenzino, B., &Beller, E. (2005). A systematic review and meta-analysis of clinical trials on physical interventions for lateral epicondylalgia. British Journal of Sports Medicine, 39(7), 411-422. https://doi.org/10.1136/bjsm.2004.016170
24. Coombes, B. K., Bisset, L., Brooks, P., Khan, A., &Vicenzino, B. (2013). Effect of corticosteroid injection, physiotherapy, or both on clinical outcomes in patients with unilateral lateral epicondylalgia: A randomized controlled trial. JAMA, 309(5), 461-469. https://doi.org/10.1001/jama.2013.129
25. Coombes, B. K., Bisset, L., &Vicenzino, B. (2010). Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: A systematic review of randomised controlled trials. The Lancet, 376(9754), 1751-1767. https://doi.org/10.1016/S0140-6736(10)61160-9
26. Creaney, L., Wallace, A., Curtis, M., & Connell, D. (2011). Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: A prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections. British Journal of Sports Medicine, 45(12), 966-971. https://doi.org/10.1136/bjsm.2010.082503
27. Edwards, S. G., &Calandruccio, J. H. (2003). Autologous blood injections for refractory lateral epicondylitis. The Journal of Hand Surgery, 28(2), 272-278. https://doi.org/10.1053/jhsu.2003.50041
28. Gosens, T., Peerbooms, J. C., van Laar, W., & den Oudsten, B. L. (2011). Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: A double-blind randomized controlled trial with 2-year follow-up. The American Journal of Sports Medicine, 39(6), 1200-1208. https://doi.org/10.1177/0363546510397173
29. Kraushaar, B. S., &Nirschl, R. P. (2001). Tendinosis of the elbow (tennis elbow). Clinical features and findings of histological, immunohistochemical, and electron microscopy studies. The Journal of Bone and Joint Surgery. American Volume, 81(2), 259-278. https://doi.org/10.2106/00004623-199902000-00014
30. Krogh, T. P., Bartels, E. M., Ellingsen, T., Stengaard-Pedersen, K., Buchbinder, R., Fredberg, U., Bliddal, H., & Christensen, R. (2013). Comparative effectiveness of injection therapies in lateral epicondylitis: A systematic review and network meta-analysis of randomized controlled trials. The American Journal of Sports Medicine, 41(6), 1435-1446. https://doi.org/10.1177/0363546512458237
31. Lebiedzinski, R., Synder, M., Buchcic, P., Polguj, M., Grzegorzewski, A., &Sibinski, M. (2015). A randomized study of autologous conditioned plasma and steroid injections in the treatment of lateral epicondylitis. International Orthopaedics, 39(11), 2199-2203. https://doi.org/10.1007/s00264-015-2861-0
32. Mishra, A., &Pavelko, T. (2006). Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. The American Journal of Sports Medicine, 34(11), 1774-1778. https://doi.org/10.1177/0363546506288850
33. Mishra, A., Woodall, J., Jr, & Vieira, A. (2009). Treatment of tendon and muscle using platelet-rich plasma. Clinics in Sports Medicine, 28(1), 113-125. https://doi.org/10.1016/j.csm.2008.08.007
34. Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gøtzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010). CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c869. https://doi.org/10.1136/bmj.c869
35. Nilsson, P., Baigi, A., Swärd, L., &Möller, M. (2008). Lateral epicondylalgia: A quantitative and qualitative analysis of interdisciplinary cooperation and treatment choice in the Swedish health care system. Scandinavian Journal of Caring Sciences, 22(4), 644-650. https://doi.org/10.1111/j.1471-6712.2007.00575.x
36. Peerbooms, J. C., Sluimer, J., Bruijn, D. J., &Gosens, T. (2010). Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: Platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. The American Journal of Sports Medicine, 38(2), 255-262. https://doi.org/10.1177/0363546509355445
37. Rompe, J. D., Overend, T. J., &MacDermid, J. C. (2007). Validation of the Patient-rated Tennis Elbow Evaluation Questionnaire. Journal of Hand Therapy, 20(1), 3-10. https://doi.org/10.1197/j.jht.2006.10.003
38. Sayegh, E. T., &Strauch, R. J. (2015). Does nonsurgical treatment improve longitudinal outcomes of lateral epicondylitis over no treatment? A meta-analysis. Clinical Orthopaedics and Related Research, 473(3), 1093-1107. https://doi.org/10.1007/s11999-014-4022-y
39. Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332. https://doi.org/10.1136/bmj.c332
40. Shiri, R., &Viikari-Juntura, E. (2011). Lateral and medial epicondylitis: Role of occupational factors. Best Practice & Research. Clinical Rheumatology, 25(1), 43-57. https://doi.org/10.1016/j.berh.2011.01.013
41. Shiri, R., Viikari-Juntura, E., Varonen, H., &Heliövaara, M. (2006). Prevalence and determinants of lateral and medial epicondylitis: A population study. American Journal of Epidemiology, 164(11), 1065-1074. https://doi.org/10.1093/aje/kwj325
42. Smidt, N., Assendelft, W. J., Arola, H., Malmivaara, A., Greens, S., Buchbinder, R., van der Windt, D. A., &Bouter, L. M. (2002). Effectiveness of physiotherapy for lateral epicondylitis: A systematic review. Annals of Medicine, 34(1), 51-62. https://doi.org/10.1080/078538902317338634
43. Thanasas, C., Papadimitriou, G., Charalambidis, C., Paraskevopoulos, I., &Papanikolaou, A. (2011). Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: A randomized controlled clinical trial. The American Journal of Sports Medicine, 39(10), 2130-2134. https://doi.org/10.1177/0363546511417113